IBEX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
IBEX is not a good immediate buy for a beginner long-term investor with $50,000-$100,000 who is unwilling to wait for a better entry. The company is fundamentally improving, but the current technical setup is weak, insider selling is heavy, options sentiment is mixed-to-bullish, and there is no fresh catalyst from news. Based on the full picture, I would not buy aggressively right now; I would hold and wait for a cleaner technical entry or a post-earnings confirmation.
Current pre-market price is 27.75. The trend is bearish: MACD histogram is slightly negative and expanding lower, RSI_6 is 41.394, which is neutral-to-weak, and moving averages are bearish with SMA_200 > SMA_20 > SMA_5. Price is also below the pivot at 28.646 and close to S1 at 27.437, which suggests the stock is sitting near short-term support rather than showing strong upside momentum. The near-term pattern model suggests only a modest 1-day bounce probability, but a weaker 1-month outlook. Overall, the chart does not support an immediate strong buy.
["Revenue in 2026/Q2 increased 16.73% YoY to 164.221M", "Net income increased 31.82% YoY to 12.217M", "EPS increased 48.21% YoY to 0.83", "Options open interest is heavily call-skewed with a 0.14 put-call ratio", "Earnings are scheduled soon on 2026-05-06 after hours, which could act as a catalyst"]
["Insiders are selling, and selling increased 5801.79% over the last month", "No recent news in the past week, so there is no fresh event-driven momentum", "Technical trend is bearish with SMA_200 > SMA_20 > SMA_5 and a negative MACD histogram", "Price is below the pivot level, indicating weak near-term trend confirmation", "Gross margin declined to 26.09%, down 2.47% YoY", "No recent congress trading data and no significant hedge fund accumulation trend"]
In 2026/Q2, Ibex delivered solid top-line and bottom-line growth. Revenue rose 16.73% YoY to 164.221M, net income increased 31.82% YoY to 12.217M, and EPS jumped 48.21% YoY to 0.83. The main weakness was gross margin, which fell to 26.09%, down 2.47% YoY. Overall, the latest quarter was growth-positive, but margin pressure is a concern.
No analyst rating or price target change data was provided, so there is no visible trend in Wall Street estimates. Based on the available data, the pros view would lean positive on earnings growth and improving EPS, while the cons view would focus on margin compression, bearish price action, and significant insider selling. Without analyst support data, the Street consensus cannot be confirmed.
